Insiders · Profile

Gamelin Erick

Chief Development Officer at Acrivon Therapeutics. Filing since 18 Aug 2026. CIK 0001950551

Company

Date

Role

Action

Amount

Of holding

18 Aug 2026

Chief Development Officer

Sold at will

400

$804.00

0.8%

1 decision on file.